ACLX Research and Charts

ACLX - Arcellx Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2025-02-06 (Delayed quote data 2025-10-28)

Last 87.49	Change ⇑ +3.42 (+4.07%)	Volume 238,200
	Open 86.64	High 88.58	Low 85.53

8EMA (Daily) 86.11	40EMA (Daily) 81.51	50EMA (Daily) 80.11	STO (Daily) 28.439	MACD Hist (Daily) -0.773
8EMA (Weekly) 82.905	40EMA (Weekly) 73.32	50EMA (Weekly) 72.06	STO (Weekly) 78.890	MACD Hist (Weekly) 1.128


Company Profile
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.